These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 11499258)

  • 1. [Application to the internist practice. The place of AT1 receptor antagonists].
    Dusleag H
    Pharm Unserer Zeit; 2001; 30(4):322-5. PubMed ID: 11499258
    [No Abstract]   [Full Text] [Related]  

  • 2. [Can Sartane help a failing heart? AT1-receptor antagonists in cardiac insufficiency].
    Düsing R
    Pharm Unserer Zeit; 2001; 30(4):314-20. PubMed ID: 11499257
    [No Abstract]   [Full Text] [Related]  

  • 3. [Concurrence to ACE inhibitors? AT1 receptor blockers and hypertension].
    Heemann U; Kribben A; Phillip T
    Pharm Unserer Zeit; 2001; 30(4):309-12. PubMed ID: 11499256
    [No Abstract]   [Full Text] [Related]  

  • 4. [Recommendations regarding AT1 receptor antagonists. Selection criteria of the drug commission].
    Kämmerer W; Sigmund M
    Pharm Unserer Zeit; 2001; 30(4):327-30. PubMed ID: 11499259
    [No Abstract]   [Full Text] [Related]  

  • 5. [AT1 receptor antagonists as single drug in hypertension? It's too early for that!].
    Dominiak P
    MMW Fortschr Med; 2001 May; 143(22):32-3. PubMed ID: 11460396
    [No Abstract]   [Full Text] [Related]  

  • 6. Angiotensin II receptor antagonists: enlarging therapeutic possibilities in arterial hypertension.
    Plante GE
    Can J Cardiol; 1999 Nov; 15 Suppl F():4F-6F. PubMed ID: 10579746
    [No Abstract]   [Full Text] [Related]  

  • 7. AT1 blockers: are there alternative pathways reducing cardiovascular risk? Introduction.
    van Zwieten PA; Julius S
    J Hypertens Suppl; 2002 Jun; 20(5):S1. PubMed ID: 12184058
    [No Abstract]   [Full Text] [Related]  

  • 8. [Risk factors in hypertension: a disease with fatal consequences].
    Mutschler E; Schubert-Zsilavecz M
    Pharm Unserer Zeit; 2001; 30(4):279. PubMed ID: 11499247
    [No Abstract]   [Full Text] [Related]  

  • 9. AT1-receptor blockers in hypertension and heart failure: clinical experience and future directions.
    Willenheimer R; Dahlöf B; Rydberg E; Erhardt L
    Eur Heart J; 1999 Jul; 20(14):997-1008. PubMed ID: 10381851
    [No Abstract]   [Full Text] [Related]  

  • 10. [ESC guidelines for therapy of heart failure. AT1 blockers are now also included].
    MMW Fortschr Med; 2002 Jan; 144(3-4):62. PubMed ID: 11862800
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacologic basics: the effect of AT1 receptor antagonists].
    Altmannsberger SH; Paneitz A; Siegmund W; Kroemer HK
    Pharm Unserer Zeit; 2001; 30(4):296-302. PubMed ID: 11499254
    [No Abstract]   [Full Text] [Related]  

  • 12. [The race for a new target. The human AT1 receptor].
    Gurrath M
    Pharm Unserer Zeit; 2001; 30(4):288-95. PubMed ID: 11499253
    [No Abstract]   [Full Text] [Related]  

  • 13. [Peripheral angiotensin II receptor blockers in clinical practice-- possibilities, indications and perspectives].
    Pallay G
    Cas Lek Cesk; 2000 Jun; Suppl():14-5, 18-32. PubMed ID: 10958033
    [No Abstract]   [Full Text] [Related]  

  • 14. [Are differences between AT1 antagonists clinically relevant? Dosage, selectivity, metabolism--critically evaluated].
    Dominiak P
    MMW Fortschr Med; 1999 Nov; 141(46):37-8. PubMed ID: 10795143
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pathophysiological and clinical implications of AT(1) and AT(2) angiotensin II receptors in essential hypertension].
    Burnier M
    Drugs; 2002; 62 Spec No 1():21-9. PubMed ID: 12036386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [German Hypertension League on the LIFE Study. New evaluation of AT1 receptor antagonists].
    Dominiak P; Zidek W
    MMW Fortschr Med; 2002 Sep; 144(38):47. PubMed ID: 12395703
    [No Abstract]   [Full Text] [Related]  

  • 17. Angiotensin II type 1 receptor blockers and congestive heart failure.
    Auer JW; Berent R; Eber B
    Circulation; 2001 Oct; 104(15):E82. PubMed ID: 11591633
    [No Abstract]   [Full Text] [Related]  

  • 18. [Isolated systolic hypertension. "AT1 blocker preferred over beta-blocker"].
    MMW Fortschr Med; 2002 Sep; 144(38):14. PubMed ID: 12395694
    [No Abstract]   [Full Text] [Related]  

  • 19. Angiotensin II receptor antagonists for the treatment of heart failure: what is their place after ELITE-II and Val-HeFT?
    McMurray JJ
    J Renin Angiotensin Aldosterone Syst; 2001 Jun; 2(2):89-92. PubMed ID: 11881104
    [No Abstract]   [Full Text] [Related]  

  • 20. The clinical profile of the angiotensin II receptor blocker eprosartan.
    Hedner T
    J Hypertens Suppl; 2002 Jun; 20(5):S33-8. PubMed ID: 12184062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.